A review of Venezuela’s current crisis has given cause for concern, highlighting the increased rate of re-emergence and spread of vector-borne diseases such as malaria, Chagas disease, dengue and Zika virus.
The accurate diagnosis of schistosomiasis, in both the mammalian and snail intermediate hosts as well as the environment, is extremely important in proper control and elimination. Despite multiple efforts over last few decades, the search for cheap, sensitive diagnostics for schistosomiasis is ongoing.
A new rapid microelectrode device for the earlier diagnosis of sepsis has been developed by researchers at the University of Strathclyde.
Researchers from the Wistar Institute have engineered a synthetic DNA vaccine able to provide potent immunity against the emerging Mayaro virus in mice models.
A biomimetic, micromotor vaccine formulation has shown promising results in immunizing against Staphylococcus aureus in mouse models.
Researchers from the Howard Hughes Medical Institute have developed a novel genetic tool for detecting fast and accurate measures of latent HIV.
Researchers from Newcastle University have reported the presence of antibiotic-resistant genes in one of the most remote, ‘unspoiled’ regions on Earth.
The UK government has published a 20-year vision and a 5-year national action plan for how the UK will contribute to controlling and containing antimicrobial resistance by 2040.
Researchers have identified a non-polio enterovirus – EV-D68 – as the potential cause of an outbreak of acute flaccid myelitis cases in Arizona.
In this infographic we take a look at the RSV vaccines currently in the clinical pipeline and their target population from Phase I to Phase III.
